Kathleen F. Kadow
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Respiratory viral infections research, Plant Virus Research Studies, Influenza Virus Research Studies, Monoclonal and Polyclonal Antibodies Research, Virology and Viral Diseases
Most-Cited Works
- → Niruriside, a New HIV REV/RRE Binding Inhibitor from Phyllanthus niruri(1996)94 cited
- → Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity(1991)80 cited
- → Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability(2006)70 cited
- → Fundamental structure–Activity relationships associated with a new structural class of respiratory syncytial virus inhibitor(2003)70 cited
- Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.(1997)
- → Fusaricide, a New Cytotoxic N-Hydroxypyridone from Fusarium sp.(1996)56 cited
- → Orevactaene,1 a novel binding inhibitor of HIV-1 rev protein to Rev response element (RRE) from Epicoccum nigrum WC47880(1997)49 cited
- → Harziphilone and Fleephilone, Two New HIV REV/RRE Binding Inhibitors Produced by Trichoderma harzianum.(1996)46 cited
- → Respiratory syncytial virus fusion inhibitors. Part 7: Structure–activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo(2009)45 cited
- → Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo(2005)41 cited